Back to Search
Start Over
Initial results from a phase IIIb/IV study evaluating two dosing regimens of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (CheckMate 511)
- Source :
- Annals of Oncology. 29:viii737
- Publication Year :
- 2018
- Publisher :
- Elsevier BV, 2018.
- Subjects :
- 0301 basic medicine
Oncology
medicine.medical_specialty
business.industry
Melanoma
Checkmate
Ipilimumab
Hematology
medicine.disease
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
medicine
In patient
Dosing
Nivolumab
business
Advanced melanoma
medicine.drug
Subjects
Details
- ISSN :
- 09237534
- Volume :
- 29
- Database :
- OpenAIRE
- Journal :
- Annals of Oncology
- Accession number :
- edsair.doi...........223342805733e71b90350face71f72fc